Inflammatory Bowel Diseases

Cover image for Vol. 17 Issue 10

October 2011

Volume 17, Issue 10

Pages 2027–2216, E128–E139

  1. Original Basic Science Articles

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Clinical Guidelines
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Letters to the Editor
    1. Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease (pages 2027–2037)

      S.C. Ng, J.L. Benjamin, N.E. McCarthy, C.R.H. Hedin, A. Koutsoumpas, S. Plamondon, C.L. Price, A.L. Hart, M.A. Kamm, A. Forbes, S.C. Knight, J.O. Lindsay, K. Whelan and A.J. Stagg

      Version of Record online: 22 DEC 2010 | DOI: 10.1002/ibd.21590

    2. Commensal gut flora reduces susceptibility to experimentally induced colitis via T-cell-derived interleukin-10 (pages 2038–2046)

      Marina C. Pils, André Bleich, Immo Prinz, Nicolas Fasnacht, Mariela Bollati-Fogolin, Angela Schippers, Björn Rozell and Werner Müller

      Version of Record online: 22 DEC 2010 | DOI: 10.1002/ibd.21587

    3. Colonic gene expression patterns of mucin muc2 knockout mice reveal various phases in colitis development (pages 2047–2057)

      Peng Lu, Nanda Burger-van Paassen, Maria van der Sluis, Janneke Witte-Bouma, Jean-Pierre Kerckaert, Johannes B. van Goudoever, Isabelle Van Seuningen and Ingrid B. Renes

      Version of Record online: 6 JAN 2011 | DOI: 10.1002/ibd.21592

    4. Longitudinal quantification of inflammation in the murine dextran sodium sulfate-induced colitis model using μPET/CT (pages 2058–2064)

      P. Hindryckx, S. Staelens, L. Devisscher, S. Deleye, F. De Vos, L. Delrue, H. Peeters, D. Laukens and M. De Vos

      Version of Record online: 16 DEC 2010 | DOI: 10.1002/ibd.21578

    5. Supplemental antioxidants do not ameliorate colitis development in HLA-B27 transgenic rats despite extremely low glutathione levels in colonic mucosa (pages 2065–2075)

      Marloes A.A. Schepens, Carolien Vink, Arjan J. Schonewille, Hennie M.J. Roelofs, Robert-Jan Brummer, Roelof van der Meer and Ingeborg M.J. Bovee-Oudenhoven

      Version of Record online: 22 DEC 2010 | DOI: 10.1002/ibd.21584

    6. Intestinal alpha-defensin expression in pediatric inflammatory bowel disease (pages 2076–2086)

      M. Zilbauer, A. Jenke, G. Wenzel, D. Goedde, J. Postberg, A.D. Phillips, M. Lucas, G. Noble-Jamieson, F. Torrente, C. Salvestrini, R. Heuschkel and S. Wirth

      Version of Record online: 16 DEC 2010 | DOI: 10.1002/ibd.21577

    7. DNFB-DNS hapten-induced colitis in mice should not be considered a model of inflammatory bowel disease (pages 2087–2101)

      Elvira Bailón, Margarita Cueto-Sola, Pilar Utrilla, Ana Nieto, Natividad Garrido-Mesa, Antonio Celada, Antonio Zarzuelo, Jordi Xaus, Julio Gálvez and Mònica Comalada

      Version of Record online: 22 DEC 2010 | DOI: 10.1002/ibd.21586

  2. Original Clinical Articles

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Clinical Guidelines
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Letters to the Editor
    1. Incidence and clinical outcomes of intersphincteric abscesses diagnosed by anal ultrasonography in patients with crohn's disease (pages 2102–2108)

      Chiara Viganò, Alessandra Losco, Flavio Caprioli and Guido Basilisco

      Version of Record online: 6 JAN 2011 | DOI: 10.1002/ibd.21596

    2. Distinguishing orofacial granulomatosis from crohn's disease: Two separate disease entities? (pages 2109–2115)

      Helen Campbell, Michael Escudier, Pritash Patel, Carlo Nunes, Timothy R. Elliott, Kate Barnard, Penelope Shirlaw, Timothy Poate, Richard Cook, Peter Milligan, Jonathan Brostoff, Alexander Mentzer, Miranda C.E. Lomer, Stephen J. Challacombe and Jeremy D. Sanderson

      Version of Record online: 6 JAN 2011 | DOI: 10.1002/ibd.21599

    3. Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent crohn's disease (pages 2116–2121)

      F.A. Farraye, H. Nimitphong, A. Stucchi, K. Dendrinos, A.B. Boulanger, A. Vijjeswarapu, A. Tanennbaum, R. Biancuzzo, T.C. Chen and M.F. Holick

      Version of Record online: 6 JAN 2011 | DOI: 10.1002/ibd.21595

    4. Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines (pages 2122–2129)

      Jason P. Etzel, Meaghan F. Larson, Bradley D. Anawalt, Judith Collins and Jason A. Dominitz

      Version of Record online: 13 JAN 2011 | DOI: 10.1002/ibd.21601

    5. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease (pages 2130–2137)

      Yoon Suk Jung, Seung Won Kim, Jin Young Yoon, Jin Ha Lee, Soung Min Jeon, Sung Pil Hong, Tae Il Kim, Won Ho Kim and Jae Hee Cheon

      Version of Record online: 6 JAN 2011 | DOI: 10.1002/ibd.21600

    6. Tolerance and efficacy of azathioprine in pediatric Crohn's disease (pages 2138–2143)

      Laura Riello, Cécile Talbotec, Hélène Garnier-Lengliné, Bénédicte Pigneur, Johan Svahn, Danielle Canioni, Olivier Goulet, Jacques Schmitz and Frank M. Ruemmele

      Version of Record online: 13 JAN 2011 | DOI: 10.1002/ibd.21612

    7. Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: A population-based study (pages 2144–2152)

      Valérie Crombé, Julia Salleron, Guillaume Savoye, Jean-Louis Dupas, Gwénola Vernier-Massouille, Eric Lerebours, Antoine Cortot, Véronique Merle, Francis Vasseur, Dominique Turck, Corinne Gower-Rousseau, Marc Lémann, Jean-Frédéric Colombel and Alain Duhamel

      Version of Record online: 1 FEB 2011 | DOI: 10.1002/ibd.21615

    8. Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994–2007) (pages 2153–2161)

      Eric I. Benchimol, Astrid Guttmann, Teresa To, Linda Rabeneck and Anne M. Griffiths

      Version of Record online: 22 DEC 2010 | DOI: 10.1002/ibd.21591

    9. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease (pages 2162–2168)

      Millie D. Long, Wallace V. Crandall, Ian H. Leibowitz, Lynn Duffy, Fernando del Rosario, Sandra C. Kim, Mark J. Integlia, James Berman, John Grunow, Richard B. Colletti, Bess T. Schoen, Ashish S. Patel, Howard Baron, Esther Israel, George Russell, Sabina Ali, Hans H. Herfarth, Christopher Martin, Michael D. Kappelman and on behalf of the ImproveCareNow Collaborative for Pediatric IBD

      Version of Record online: 17 DEC 2010 | DOI: 10.1002/ibd.21585

  3. Clinical Guidelines

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Clinical Guidelines
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Letters to the Editor
    1. You have free access to this content
  4. Clinical Reviews

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Clinical Guidelines
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Letters to the Editor
    1. Thromboembolism in pediatric inflammatory bowel disease: Systematic review (pages 2174–2183)

      Marzia Lazzerini, Matteo Bramuzzo, Massimo Maschio, Stefano Martelossi and Alessandro Ventura

      Version of Record online: 3 DEC 2010 | DOI: 10.1002/ibd.21563

    2. Development of process and outcome measures for improvement: Lessons learned in a quality improvement collaborative for pediatric inflammatory bowel disease (pages 2184–2191)

      Wallace V. Crandall, Brendan M. Boyle, Richard B. Colletti, Peter A. Margolis and Michael D. Kappelman

      Version of Record online: 31 MAR 2011 | DOI: 10.1002/ibd.21702

  5. Basic Science Reviews

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Clinical Guidelines
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Letters to the Editor
    1. You have free access to this content
      New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease (pages 2192–2204)

      Darla R. Shores, David G. Binion, Bruce A. Freeman and Paul R.S. Baker

      Version of Record online: 3 DEC 2010 | DOI: 10.1002/ibd.21560

  6. Letters to the Editor

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Clinical Guidelines
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Letters to the Editor
    1. Gene expression of carnitine organic cation transporters 1 and 2 (OCTN) is downregulated in patients with ulcerative colitis (pages 2205–2206)

      Jesús K. Yamamoto-Furusho, Edgar J. Mendivil-Rangel, Marco A. Villeda-Ramírez, Gabriela Fonseca-Camarillo and Rafael Barreto-Zuñiga

      Version of Record online: 22 DEC 2010 | DOI: 10.1002/ibd.21621

    2. Crohn's disease and liver abscess due to Pediococcus sp. (pages 2207–2208)

      Jaime López Bernabeu, Eduardo Leo, Claudio Trigo, Jose Manuel Herrera, Jose Manuel Sousa and Jose Luis Marquez

      Version of Record online: 1 FEB 2011 | DOI: 10.1002/ibd.21622

    3. Role of the interleukin 24 in patients with ulcerative colitis (pages 2209–2210)

      Gabriela Fonseca Camarillo, Janette Furuzawa-Carballeda, Braulio Martínez-Benítez, Rafael Barreto-Zúñiga and Jesús K. Yamamoto-Furusho

      Version of Record online: 1 FEB 2011 | DOI: 10.1002/ibd.21635

    4. Importance of CXCL16 as a biomarker for granulocytapheresis in patients with Crohn's disease (pages 2211–2212)

      Hiroshi Nakase, Norimitsu Uza, Minoru Matsuura and Tsutomu Chiba

      Version of Record online: 9 MAR 2011 | DOI: 10.1002/ibd.21657

    5. Smoking therapy may be an extreme cure in exsmokers with steroid-dependent and resistant ulcerative colitis (page 2213)

      Mario Cottone, Amvrosiadis Georgios and Emanuele Sinagra

      Version of Record online: 23 FEB 2011 | DOI: 10.1002/ibd.21658

    6. Cerebral sinus thrombosis in ulcerative colitis (pages 2214–2216)

      Giovanni Casella, Chiara Spreafico, Marilena Costantini, Fabio Pagni, Claudio Camillo Cortelezzi, Vittorio Baldini, Maria Luisa DeLodovici and Giorgio Bono

      Version of Record online: 23 FEB 2011 | DOI: 10.1002/ibd.21659

    7. Identification of Mycobacterium cosmeticum sp. as a novel colitogenic infectious agent in a nonimmunocompromised patient (pages E128–E130)

      Gilles Boschetti, Eddy Cotte, Driffa Moussata, Marion Chauvenet, Franck Breysse, Monique Chomarat, Sylvie Isaac, Françoise Berger, Dominique Kaiserlian, Stéphane Nancey and Bernard Flourie

      Version of Record online: 7 JUL 2011 | DOI: 10.1002/ibd.21804

    8. Patient knowledge in inflammatory bowel disease: CCKNOW, how much do they know? (pages E131–E132)

      Rhys Owain Butcher, Tina L. Law, Roger C. Prudham and Jimmy K. Limdi

      Version of Record online: 7 JUL 2011 | DOI: 10.1002/ibd.21810

    9. Cryptosporidiosis masquerading as a Crohn's flare (pages E133–E134)

      Jason Ferreira, Rachel Baden, Suma Magge and Adam Cheifetz

      Version of Record online: 7 JUL 2011 | DOI: 10.1002/ibd.21811

    10. Interleukin 17 gene and protein expression are increased in patients with ulcerative colitis (pages E135–E136)

      Gabriela Fonseca-Camarillo, Edgar Mendivil-Rangel, Janette Furuzawa-Carballeda and Jesus K. Yamamoto-Furusho

      Version of Record online: 14 JUL 2011 | DOI: 10.1002/ibd.21816

SEARCH

SEARCH BY CITATION